DE LUCA, GIUSEPPE
 Distribuzione geografica
Continente #
EU - Europa 11.334
NA - Nord America 9.313
AS - Asia 6.320
SA - Sud America 1.433
AF - Africa 145
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 6
Totale 28.565
Nazione #
US - Stati Uniti d'America 9.133
RU - Federazione Russa 3.226
IE - Irlanda 2.799
SG - Singapore 1.806
CN - Cina 1.674
DE - Germania 1.532
HK - Hong Kong 1.161
UA - Ucraina 1.116
BR - Brasile 1.074
SE - Svezia 1.030
VN - Vietnam 901
FI - Finlandia 546
FR - Francia 473
IN - India 258
IT - Italia 216
GB - Regno Unito 157
AR - Argentina 135
CA - Canada 93
ID - Indonesia 87
MX - Messico 68
KR - Corea 65
BD - Bangladesh 61
EC - Ecuador 57
ZA - Sudafrica 51
IR - Iran 50
CO - Colombia 48
PL - Polonia 45
IQ - Iraq 41
NL - Olanda 41
PY - Paraguay 40
JP - Giappone 32
VE - Venezuela 32
ES - Italia 31
AT - Austria 28
TR - Turchia 27
PK - Pakistan 26
MA - Marocco 22
CL - Cile 21
BE - Belgio 18
SA - Arabia Saudita 18
CZ - Repubblica Ceca 16
PH - Filippine 15
KZ - Kazakistan 13
LT - Lituania 13
TN - Tunisia 13
EU - Europa 12
KE - Kenya 11
RO - Romania 11
AE - Emirati Arabi Uniti 10
DZ - Algeria 10
EG - Egitto 10
PE - Perù 10
UY - Uruguay 10
UZ - Uzbekistan 10
JO - Giordania 9
TH - Thailandia 9
BJ - Benin 8
IL - Israele 7
AZ - Azerbaigian 5
NP - Nepal 5
RS - Serbia 5
AL - Albania 4
HU - Ungheria 4
JM - Giamaica 4
LB - Libano 4
MY - Malesia 4
AU - Australia 3
BO - Bolivia 3
BW - Botswana 3
BY - Bielorussia 3
GR - Grecia 3
HR - Croazia 3
KG - Kirghizistan 3
NG - Nigeria 3
PS - Palestinian Territory 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
BG - Bulgaria 2
BH - Bahrain 2
CG - Congo 2
CR - Costa Rica 2
ET - Etiopia 2
GA - Gabon 2
GT - Guatemala 2
GY - Guiana 2
HN - Honduras 2
KW - Kuwait 2
LV - Lettonia 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
OM - Oman 2
PA - Panama 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
CI - Costa d'Avorio 1
Totale 28.545
Città #
Dublin 2.798
Jacksonville 1.915
Hong Kong 1.158
Dearborn 1.051
San Jose 836
Singapore 723
Wilmington 701
Ashburn 530
Moscow 481
Beijing 456
Lawrence 382
Princeton 382
Lauterbourg 342
Ho Chi Minh City 301
San Mateo 261
Chandler 254
Los Angeles 215
Hanoi 176
Ann Arbor 168
Bremen 165
Andover 163
Buffalo 154
São Paulo 104
Hefei 74
Redondo Beach 70
Houston 68
Düsseldorf 67
Nanjing 66
New York 63
Seoul 63
Orem 56
Norwalk 54
Woodbridge 51
Kunming 50
Guangzhou 49
Munich 49
Dallas 48
Tianjin 47
Haiphong 42
Rio de Janeiro 42
Santa Clara 42
Piemonte 40
Frankfurt am Main 37
Nuremberg 37
Jinan 36
Leawood 36
Da Nang 35
Fairfield 35
Helsinki 34
Monmouth Junction 33
Warsaw 33
Chennai 32
Denver 32
Toronto 31
Hangzhou 29
Johannesburg 29
Tokyo 28
Mexico City 26
Montreal 26
Biên Hòa 25
Manchester 25
Seattle 25
Amsterdam 22
Ardabil 22
Poplar 21
Nanchang 20
Stockholm 20
Torino 20
Guayaquil 19
London 19
Shanghai 19
Shenzhen 19
Brussels 18
Chicago 18
Quito 18
Atlanta 17
Belo Horizonte 16
Brno 16
Bắc Ninh 16
Campinas 16
Dong Ket 16
Hebei 16
Hải Dương 16
Jakarta 16
Phoenix 16
Brasília 15
Curitiba 15
Guarulhos 15
Bexley 14
Boston 14
Brooklyn 14
Can Tho 14
New Delhi 14
Ribeirão Preto 14
Rome 14
Shenyang 14
Baghdad 13
Boardman 13
Buenos Aires 13
Xian 13
Totale 16.006
Nome #
Impact of gender difference on vitamin D status and its relationship with the extent of coronary artery disease 134
Analysis of beta1 and beta2-adrenergic receptors polymorphism in patients with apical ballooning cardiomyopathy 134
Mean platelet volume is not associated with platelet reactivity and the extent of coronary artery disease in diabetic patients 132
Platelet PIA1/PIA2 polymorphism and the risk of periprocedural myocardial infarction in patients with acute coronary syndromes undergoing coronary angioplasty. 130
Association between high-residual platelet reactivity in patients receiving dual antiplatelet therapy, Vitamin D plasma levels and Vitamin D Binding Protein rs7041 polymorphism. 127
P2Y12 inhibitors: pharmacologic mechanism and clinical relevance 126
Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease. 125
Coronary intravascular ultrasound (IVUS): Contemporary applications and bases for the future 124
Combination between mean platelet volume and platelet distribution width to predict the prevalence and extent of coronary artery disease: results from a large cohort study 123
Acetylsalicylic acid desensitization in patients with coronary artery disease: A comprehensive overview of currently available protocols 123
Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor. 122
ACC/AHA and ESC guidelines 121
Mechanical reperfusion for STEMI: from randomized trials to clinical practice 121
Cytokines release inhibition from activated monocytes, and reduction of in-stent neointimal growth in humans 121
PCI techniques 120
Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor: Reply 120
Bivalirudin as compared to unfractionated heparin among patients undergoing coronary angioplasty A meta-analyis of randomised trials 119
Apical-sparing Tako-tsubo: A case report 118
Aspirin desensitization in patients undergoing planned or urgent coronary stent implantation. A single-center experience. 118
Impact of Long-Term Dual Antiplatelet Therapy on Immature Platelet Count and Platelet Reactivity 117
ANMCO/SICI-GISE paper on antiplatelet therapy in acute coronary syndrome 116
Paclitaxel-eluting versus bare metal stents in primary PCI: a pooled patient-level meta-analysis of randomized trials. 116
Switching from clopidogrel to prasugrel in patients having coronary stent implantation. 116
Neutrophil to Lymphocyte Ratio and the Extent of Coronary Artery Disease: Results from a Large Cohort Study 116
Diabetes mellitus, glucose control parameters and platelet reactivity in ticagrelor treated patients 115
Body Mass Index and Platelet Reactivity During Dual Antiplatelet Therapy With Clopidogrel or Ticagrelor 115
Optical coherence tomography for guidance of treatment of in-stent restenosis with cutting balloons. 114
An unusual case of ECG ST-segment elevation 114
Impact of long-term dual antiplatelet therapy on immature platelet count and platelet reactivity. 114
Association between high-residual platelet reactivity in patients receiving dual antiplatelet therapy, Vitamin D plasma levels and Vitamin D Binding Protein rs7041 polymorphism. 112
Adjuncitve pharmacotherapy: Anticoagulation 111
Advances in antithrombotic therapy as adjunct to reperfusion therapies for ST-segment elevation myocardial infarction 111
Absolute eosinophils count and the extent of coronary artery disease: a single centre cohort study. 111
Platelet HPA-1 a/HPA-1 b polymorphism and the risk of periprocedural myocardial infarction in patients undergoing elective PCI. 111
Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor 111
Impact of diabetes on neutrophil-to-lymphocyte ratio and its relationship to coronary artery disease 111
Impact of age on mean platelet volume and its relationship with coronary artery disease: A single-centre cohort study 111
Impact of duration of clopidogrel prescription on outcome of DES as compared to BMS in primary angioplasty: a meta-regression analysis of randomized trials 110
Impact of hypertension on clinical outcome in STEMI patients undergoing primary angioplasty with BMS or DES: insights from the DESERT cooperation. 110
Cholecalciferol levels, inflammation and leukocytes parameters: Results from a large single-centre cohort of patients 110
Glycosylated hemoglobin and the risk of periprocedural myocardial infarction in non-diabetic patients 109
Bivalirudin as compared to unfractionated heparin in patients undergoing percutaneous coronary revascularization: A meta-analysis of 22 randomized trials 109
Haemoglobin levels do not correlate with the extent of coronary artery disease: results from a large cohort study. 109
Impact of adenosine A2a receptor polymorphism rs5751876 on platelet reactivity in ticagrelor treated patients 109
Impact of multivessel disease on myocardial perfusion and survival among patients undergoing primary percutaneous coronary intervention with glycoprotein IIb/IIIa inhibitors. 108
Homocysteine levels and platelet reactivity in coronary artery disease patients treated with ticagrelor 108
Platelet reactivity in patients with impaired renal function receiving dual antiplatelet therapy with clopidogrel or ticagrelor 107
Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease. 107
Immature platelet fraction and the extent of coronary artery disease: a single centre study. 107
Antithrombotic therapies in primary angioplasty:rationale, results and future directions 106
Impact of metabolic syndrome on mean platelet volume and its relationship with coronary artery disease 106
Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. 106
Redefining the success of mechanical reperfusion: ST-segment resolution 105
Impact of advanced age on myocardial perfusion, distal embolization, and mortality patients with ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb-IIIa inhibitors. 105
Dual Versus Single Antiplatelet Regimen With or Without Anticoagulation in Transcatheter Aortic Valve Replacement: Indirect Comparison and Meta-analysis 105
Association between high-residual platelet reactivity in patients receiving dual antiplatelet therapy, Vitamin D plasma levels and Vitamin D Binding Protein rs7041 polymorphism. 105
Benefits from new ADP-antagonists as compared to clopidogrel in patients with stable angina or acute coronary syndrome undergoing invasive management: a meta-analysis of randomized trials. 105
Adjunctive manual thrombectomy improves myocardial perfusion and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized trials 105
Impact of Diabetes on Homocysteine Levels and Its Relationship with Coronary Artery Disease: A Single-Centre Cohort Study 104
Adjunctive benefits from low-molecular-weight heparins as compared to unfractionated heparin among patients with ST-segment elevation myocardial infarction treated with thrombolysis. A meta-analysis of the randomized trials 104
Direct coronary stenting: Effects on coronary blood flow, immediate and late clinical outcome 103
Old and New Drugs for Treatment of Stable Angina: New Anti-Anginal Drugs and Coronary Revascularization. 103
Randomized evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: Rationale and design of the REDUCE trial 103
Relationship Between Glycoprotein IIIa Platelet Receptor Gene Polymorphism and Coronary Artery Disease 103
Pharmacological facilitation in primary angioplasty: myth or reality? 102
Impact of diabetes on uric acid and its relationship with the extent of coronary artery disease and platelet aggregation: a single-centre cohort study. 102
Comprehensive meta-analysis of radial vs femoral approach in primary angioplasty for STEMI. 102
Impact of Preprocedural TIMI Flow on Myocardial Perfusion, Distal Embolization and Mortality in Patients with ST-Segment Elevation Myocardial Infarction Treated by Primary Angioplasty and Glycoprotein IIb/IIIa Inhibitors 102
A meta-analytic overview of thrombectomy during primary angioplasty 101
Aging, impaired myocardial perfusion and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty 101
Radial vs femoral approach in acute coronary syndromes: A meta-analysis of randomized trials 100
Immature platelet fraction and the extent of coronary artery disease: a single centre study. 100
High-Density Lipoproteins and Coronary Artery Disease: A Single-Center Cohort Study 98
Mechanical prevention of distal embolization: Rationale and trial results 97
Left ventricular angiography and other angiocardiographic techniques 97
Preprocedural β-Blockers in the Functional Assessment of Intermediate Coronary Lesions by Instantaneous Wave-Free Ratio 97
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 96
A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale 96
Impact of diabetes on fibrinogen levels and its relationship with platelet reactivity and coronary artery disease: A single-centre study 96
Prevalence and predictors of high-on treatment platelet reactivity with ticagrelor in ACS patients undergoing stent implantation. 96
Antithrombotic Therapy After Percutaneous Aortic Valve Implantation: Large Gaps for a Matter of Extreme Importance. Response 96
Time-related impact of distal embolisation on myocardial perfusion and survival among patients undergoing primary angioplasty with glycoprotein IIb-IIIa inhibitors: insights from the EGYPT cooperation. 96
Duration of dual antiplatelet therapy and outcome in patients with acute coronary syndrome undergoing percutaneous revascularization: A meta-analysis of 11 randomized trials 96
Benefits from intracoronary as compared to intravenous abciximab administration for STEMI patients undergoing primary angioplasty: a meta-analysis of 8 randomized trials. 95
Absence of seasonal variation in myocardial perfusion, enzymatic infarct size, and mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty 95
Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease 95
Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register 94
Long-term outcome of drug-eluting stents compared with bare metal stents in st-segment elevation myocardial infarction results of the paclitaxel- or sirolimus-eluting stent versus bare metal stent in primary angioplasty (paseo) randomized trial (Retraction in: Circulation (2010) 121:8 (e228)) 94
Balloon angioplasty or BMS? 93
Prevalence and predictors of high-on treatment platelet reactivity with ticagrelor in ACS patients undergoing stent implantation 93
Impact of anticoagulation strategy with bivalirudin or heparin on nonaccess site bleeding in percutaneous coronary interventions: A meta-analysis of randomized trials 93
Optical coherence tomography guidance during bioresorbable vascular scaffold implantation 92
Impact of increasing dose of intracoronary adenosine on peak hyperemia duration during fractional flow reserve assessment 92
Gender differences in platelet reactivity in diabetic patients receiving dual antiplatelet therapy 92
Immature platelet fraction and the extent of coronary artery disease: A single centre study 91
Homocysteine levels influence platelet reactivity in coronary artery disease patients treated with acetylsalicylic acid. 91
Impact of long-term therapy with acetylsalicylic acid on immature platelet count: a single-centre cohort study 91
Effects of HDL-modifiers on cardiovascular outcomes: A meta-analysis of randomized trials. 90
Risk and Benefits of Triple Therapy in Patients Undergoing Coronary Stent Implantation Requiring Oral Anticoagulation: A Meta-Analysis of 16 Studies 90
Serum uric acid levels during dual antiplatelet therapy with ticagrelor or clopidogrel: Results from a single-centre study 90
Totale 10.713
Categoria #
all - tutte 155.032
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 155.032


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021458 0 0 0 0 0 0 0 0 0 35 395 28
2021/20222.083 72 54 302 135 200 8 163 35 155 60 385 514
2022/20234.395 412 147 211 54 246 262 81 193 2.640 8 87 54
2023/20241.236 65 71 78 18 279 2 225 20 3 9 188 278
2024/20252.968 55 29 98 21 70 387 280 234 936 350 62 446
2025/202610.436 364 374 1.088 1.920 737 819 1.866 1.999 743 526 0 0
Totale 29.322